2022-RA-443-ESGO Lymph node involvement in early-stage cervical cancer: is the lymphangiogenesis a risk factor? Results of MICROCOL study. (20th October 2022)
- Record Type:
- Journal Article
- Title:
- 2022-RA-443-ESGO Lymph node involvement in early-stage cervical cancer: is the lymphangiogenesis a risk factor? Results of MICROCOL study. (20th October 2022)
- Main Title:
- 2022-RA-443-ESGO Lymph node involvement in early-stage cervical cancer: is the lymphangiogenesis a risk factor? Results of MICROCOL study
- Authors:
- Tantari, Matteo
Bogliolo, Stefano
Morotti, Matteo
Balaya, Vincent
Boutitie, Florent
Buenerd, Annie
Magaud, Laurent
Lécuru, Fabrice
Guani, Benedetta
Mathevet, Patrice - Abstract:
- Abstract : Introduction/Background: In patients with cervical cancer, the presence of tumoral lymph-vascular space invasion (LVSI) is the main risk factor for pelvic lymph node metastasis (PLNM). The objective of this study was to evaluate the presence of several markers of lymphangiogenesis in early-stage cervical cancer and their correlation with PLNM and tumoral recurrence. Methodology: Patients with early-stage cervical carcinoma underwent sentinel lymph node (SLN) sampling in association with complete pelvic lymph node dissection. Primary tumors were stained with the following markers: Ki67, D2–40, CD31 and VEGF-C. A 3 years follow-up was performed to evaluate the disease-free survival. Results: Overall, 14 patients (18.6%) had PLNM. Positive LVSI was seen in 29 patients (38.6%). There was a significant correlation between LVSI evidenced by H/E staining and PLNM (p<0.001). There was no correlation between high Ki67, CD31, D2–40, and VEGF-C staining with PLNM or tumor recurrence. Conclusion: Our data support lymphatic spread does not require the proliferation of new lymphatic endothelial cells in early-stage cervical cancer. These results emphasize the importance of pre-existing peritumoral lymphatic vessels in the metastatic process in early cervical cancer. None of the markers of lymphangiogenesis and proliferation assessed in this study were predictive of PLNM or recurrence.
- Is Part Of:
- International journal of gynecological cancer. Volume 32(2022)Supplement 2
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 32(2022)Supplement 2
- Issue Display:
- Volume 32, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 32
- Issue:
- 2
- Issue Sort Value:
- 2022-0032-0002-0000
- Page Start:
- A11
- Page End:
- A12
- Publication Date:
- 2022-10-20
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2022-ESGO.25 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24569.xml